193
Views
1
CrossRef citations to date
0
Altmetric
Meta-analysis

Effect of primary tumor resection on survival in patients with asymptomatic unresectable metastatic colorectal cancer: a systematic review and meta-analysis

ORCID Icon, , ORCID Icon, , , , , & show all
Pages 107-115 | Received 07 Aug 2022, Accepted 09 Oct 2022, Published online: 25 Nov 2022

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209–249.
  • Ferlay J, Colombet M, Soerjomataram I, et al. 2018Nov Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018, European journal of cancer (Oxford, England: 1990) Vol. 103, 356–387.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019 Jan;69(1):7–34.
  • Ergun Y, Bal O, Dogan M, et al. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer? J Res Med Sci. 2020;25:14.
  • Simillis C, Kalakouti E, Afxentiou T, et al. Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: a Systematic Review and Meta-analysis. World J Surg. 2019 Jul;43(7):1829–1840.
  • Arhin ND, Shen C, Bailey CE, et al. Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients. Cancer Med. 2021 Jul;10(13):4269–4281.
  • Rajakannu M, Magdeleinat P, Vibert E, et al. Is cure possible after sequential resection of hepatic and pulmonary metastases from colorectal cancer? Clin Colorectal Cancer. 2018 Mar;17(1):41–49.
  • Pędziwiatr M, Mizera M, Witowski J, et al. In: Primary tumor resection in stage IV unresectable colorectal cancer: what has changed? Medical oncology (Northwood London England). 2017 Oct 30;34( 12):188.
  • Yun J-A, Huh JW, Park YA, et al. The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer. Dis Colon Rectum. 2014 Sep;57(9):1049–1058.
  • Ha GW, Kim JH, Lee MR. Meta-analysis of oncologic effect of primary tumor resection in patients with unresectable stage IV colorectal cancer in the era of modern systemic chemotherapy. Ann Surg Treat Res. 2018 Aug;95(2):64–72.
  • Kanemitsu Y, Shitara K, Mizusawa J, et al. Primary Tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial. J Clin Oncol. [2021 Apr 1];39(10):1098–+.
  • National Guideline A. NICE evidence reviews collection. Surgery for asymptomatic primary tumour: colorectal cancer (update): evidence review D1. Vol. 2020. London: National Institute for Health and Care Excellence (NICE)Copyright © NICE; 2020.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. [2009 Jul 21];6(7):e1000097.
  • Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019 Oct 3;10:Ed000142
  • Xiu-xia L, Ya Z, Yao-long C, et al. The reporting characteristics and methodological quality of Cochrane reviews about health policy research. Health policy (Amsterdam Netherlands). 2015 Apr 4; 119(4):503–510.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010 Sep;25(9):603–605.
  • Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014 Apr 1;14:45.
  • Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998 Dec 30;17(24):2815–2834.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003 Sep 6;327(7414):557–560.
  • Patsopoulos NA, Evangelou E, Ioannidis JP. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008 Oct;37(5):1148–1157.
  • Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000 Jun;56(2):455–463.
  • Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997 Sep 13;315(7109):629–34.
  • Sutton AJ, Duval SJ, Tweedie RL et al, , Empirical assessment of effect of publication bias on meta-analyses. BMJ (Clinical research ed). 2000 Jun 10;320(7249):1574–7.
  • Huang M, Yang Y, Li Q, et al. Induction chemotherapy followed by primary tumor resection did not bring survival benefits in colon cancer patients with asymptomatic primary lesion and synchronous unresectable metastases. Front Oncol. 2022 Jan 31;12:747124.
  • Park EJ, Baek J-H, Choi G-S, et al. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous, unresectable metastasis: a multicenter randomized controlled trial. Cancers (Basel). 2020 Aug;12(8):2306.
  • Watanabe A, Yamazaki K, Kinugasa Y, et al. Influence of primary tumor resection on survival in asymptomatic patients with incurable stage IV colorectal cancer. Int J Clin Oncol. 2014 Dec;19(6):1037–1042.
  • Doah KY, Shin US, Jeon BH, et al. The impact of primary tumor resection on survival in asymptomatic colorectal cancer patients with unresectable metastases. Ann Coloproctol. 2021 Apr;37(2):94–100.
  • Matsumoto T, Hasegawa S, Matsumoto S, et al. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor. Dis Colon Rectum. 2014 Jun;57(6):679–686.
  • Samalavicius NE, Dulskas A, Baltruskeviciene E, et al. Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not? Videosurgery Other Miniinvasive Tech. 2016;11(4):274–282.
  • Ferrand F, Malka D, Bourredjem A, et al. Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601. Eur J Cancer. 2013 Jan;49(1):90–97.
  • Rahbari NN, Lordick F, Fink C, et al. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS–a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer. 2012 Apr 5;12:142.
  • Biondo S, Frago R, Kreisler E, et al. Impact of resection versus no resection of the primary tumor on survival in patients with colorectal cancer and synchronous unresectable metastases: protocol for a randomized multicenter study (CR4). Int J Colorectal Dis. 2017 Jul;32(7):1085–1090.
  • Poultsides GA, Paty PB. Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective. Ther Adv Med Oncol. 2011 Jan;3(1):35–42.
  • Tappenden P, Jones R, Paisley S, et al. In: Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. 2007 Mar. Vol. 11. Health technology assessment: Winchester England. 12. 1–128, iii–iv.
  • Golfinopoulos V, Salanti G, Pavlidis N, et al. Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. Lancet Oncol. 2007 Oct;8(10):898–911.
  • Hochster HS, Hart LL, Ramanathan RK, et al. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. J Clin Oncol. [2008 Jul 20];26(21):3523–3529.
  • Lee K-C, Y-C O, W-H H, et al. Meta-analysis of outcomes of patients with stage IV colorectal cancer managed with chemotherapy/radiochemotherapy with and without primary tumor resection. Onco Targets Ther. 2016;9:7059–7069.
  • Anwar S, Peter MB, Dent J, et al. Palliative excisional surgery for primary colorectal cancer in patients with incurable metastatic disease. Is there a survival benefit? A systematic review. Colorectal Dis. 2012 Aug;14(8):920–930.
  • Clancy C, Burke JP, Barry M, et al. A meta-analysis to determine the effect of primary tumor resection for stage IV colorectal cancer with unresectable metastases on patient survival. Ann Surg Oncol. 2014 Nov;21(12):3900–3908.
  • Stillwell AP, Buettner PG, Ho YH. Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg. 2010 Apr;34(4):797–807.
  • Shu Y, Xu L, Yang W, et al. Asymptomatic primary tumor resection in metastatic colorectal cancer: a systematic review and meta-analysis. Front Oncol. 2022;12:836404.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.